(Q39452637)

12 September 2017

Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions (English)

1 reference

12 September 2017

Andrew M Lew

5

0 references

author name string

Megan J Brooks

1

1 reference

12 September 2017

Elena I Burtseva

2

1 reference

12 September 2017

Philip J Ellery

3

1 reference

12 September 2017

Glenn A Marsh

4

1 reference

12 September 2017

Anatoly N Slepushkin

6

1 reference

12 September 2017

Suzanne M Crowe

7

1 reference

12 September 2017

Gregory A Tannock

8

1 reference

12 September 2017

25 October 2011

1 reference

Journal of Medical Virology

12 September 2017

1 reference

12 September 2017

84

1 reference

12 September 2017

1

1 reference

12 September 2017

170-181

1 reference

Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa

12 September 2017

1 reference

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection

21 January 2018

1 reference

Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance

21 January 2018

1 reference

Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines

21 January 2018

1 reference

Comparison of neuraminidases of the same subtype but from different species using a new method of titration

21 January 2018

1 reference

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

21 January 2018

1 reference

Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice

21 January 2018

1 reference

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

21 January 2018

1 reference

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series

21 January 2018

1 reference

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

21 January 2018

1 reference

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol

21 January 2018

1 reference

Neuraminidase inhibitors: zanamivir and oseltamivir

21 January 2018

1 reference

Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus

21 January 2018

1 reference

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

21 January 2018

1 reference

Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo

21 January 2018

1 reference

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

21 January 2018

1 reference

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

21 January 2018

1 reference

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

21 January 2018

1 reference

Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds

21 January 2018

1 reference

A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers

21 January 2018

1 reference

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

21 January 2018

1 reference

Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine

21 January 2018

1 reference

Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.22234

1 reference

release_64dgbk4virgrpepkrmq4vm4jla

12 September 2017

0 references

1 reference